Reconstituting 5mg Tirzepatide: Why the Question Itself Is a Red Flag

Licensed Mounjaro (tirzepatide) at every strength (including 5mg) is a pre-filled, ready-to-inject solution. No powder, no solvent, no mixing step.
Reconstitution is a process associated with unlicensed compounded or counterfeit tirzepatide, not the genuine MHRA-authorised product.
The MHRA has warned publicly about fake and illegally traded GLP-1 pens, including tirzepatide; around 20 million doses worth approximately £45 million were seized in 2025 alone.
Reporting a suspect seller or product (including anything requiring reconstitution and sold as tirzepatide) can be done directly through the MHRA's Yellow Card scheme.

If you're searching for how to reconstitute 5mg tirzepatide, the short answer is: you shouldn't need to. Licensed Mounjaro — the only tirzepatide medicine approved by the MHRA for weight management in the UK — arrives as a ready-to-use solution inside a pre-filled KwikPen. There is nothing to mix, measure or reconstitute. The fact that reconstitution instructions exist at all points to a different, and concerning, supply chain. This page explains what licensed tirzepatide actually looks like, why reconstitution queries have become so common, and what that means for patient safety. Mounjaro's full profile, including how it works and who it's licensed for, is covered separately if you'd like the broader picture first.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What licensed 5mg tirzepatide looks like, why reconstitution appears online, and what to do about it

Step 1: Understand what genuine licensed 5mg tirzepatide actually is

Mounjaro is supplied by Eli Lilly in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Every single one of them is a clear, colourless liquid already inside a pre-filled KwikPen, one pen contains four weekly doses. When you receive a genuine 5mg pen through a GPhC-registered pharmacy, the only preparation required is letting it reach room temperature if it's come straight from the fridge, wiping the injection site, attaching the needle, and injecting. That's the complete process. The NHS tirzepatide patient information page describes the injection steps and confirms this ready-to-use format. There is no vial. There is no powder to dissolve. There is no syringe to fill. If a product described as tirzepatide requires you to mix anything (a lyophilised powder with bacteriostatic water, for example) it is not the licensed medicine.

At nume (sorry, at a legitimate UK pharmacy like the one behind this service) a genuine 5mg pen arrives in plain, unbranded packaging via DPD with a tracking notification on your phone the morning it's out for delivery. It looks unremarkable. Inside is a single pen, a package leaflet, and nothing else. No vials, no mixing instructions.

Step 2: Recognise why reconstitution guides are circulating online

The surge in demand for GLP-1 medicines has outpaced licensed supply at various points since 2023, and unlicensed compounding operations have filled that gap illegally. Compounded tirzepatide (sometimes sold as a powder or lyophilised cake requiring reconstitution with bacteriostatic water) is not approved by the MHRA, has not been assessed for quality, purity or stability, and does not carry the same safety guarantees as the licensed product. It may also be an outright counterfeit: in October 2025 the MHRA raided the first known illicit UK manufacturing site producing counterfeit tirzepatide pens, in Northampton, as part of a wider enforcement operation that seized around 20 million doses of illegally traded weight-loss medicines with a street value of approximately £45 million. Some counterfeit pens in earlier seizures were found to contain insulin rather than the labelled medicine, causing serious harm to people who used them. Reconstitution instructions, then, are not a sign of a more advanced or flexible product. They are a sign that what you're looking at is not what it claims to be. If you want context on what the 5mg dose is actually used for within a licensed treatment course, the 5mg Mounjaro page covers the dose's role in the titration schedule.

Step 3: Know the safety stakes and the right route forward

Injecting a product of unknown composition carries real risks: infection from non-sterile preparation, incorrect concentration leading to overdose or underdose, allergic reactions to unlicensed excipients, and the possibility of an entirely different active ingredient. These are not theoretical. The MHRA's enforcement communications and the earlier counterfeit warnings document actual hospitalisations linked to fake pens. This is also why the legal framework around Mounjaro matters. Tirzepatide is a Prescription-Only Medicine under the Human Medicines Regulations 2012. A clinical assessment by a qualified prescriber is not a bureaucratic hurdle, it's the mechanism that matches the right medicine, at the right dose, to the right person, with appropriate monitoring. Anyone offering tirzepatide in a form requiring reconstitution, or selling it without a prescription following clinical assessment, is operating outside that framework. If you've already received a product requiring reconstitution and aren't sure what to do, contact your GP or call 111. You can also report the supplier through the MHRA Yellow Card scheme.

For people looking to access licensed tirzepatide through a regulated private route, the detailed guidance on 5mg tirzepatide reconstitution questions addresses the topic from a patient-safety angle if you'd like more background before starting a consultation. The common reconstitution search queries are also addressed there. Patients who have encountered unlicensed products at higher doses may also find it useful to read our guidance on reconstituting tirzepatide 10mg, which explains why that process has no place in licensed treatment, and the same patient-safety perspective applies to anyone who has come across instructions for 10mg tirzepatide reconstitution, a process that exists only in the context of unlicensed or counterfeit products. A GPhC-registered Independent Prescriber reads every consultation submitted through our free assessment the same day, a real clinician, not automated software. The process is straightforward: a free consultation, clinical review, and if approved, a genuine pre-filled pen dispatched the same day for free next-working-day delivery. There is nothing to reconstitute. That simplicity is precisely the point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions